CBSET Email Format
Research ServicesMassachusetts, United States51-200 Employees
CBSET is a preclinical translational research institute based in Lexington, Massachusetts, focused on advancing early-stage biomedical technologies. Its work supports sponsors seeking to translate discoveries into practical tools and methods that enable earlier diagnosis and the development of innovative treatments for complex diseases. The organization concentrates on developing and applying minimally invasive approaches across cardiology, endoscopy, surgery, drug and device delivery, safety assessment, and diagnostic imaging, bridging laboratory research with preclinical validation. Operating in the research services space, CBSET serves biotech and life sciences sponsors seeking preclinical validation of new technologies. In 2026 the company announced expansion plans to add large new facilities in Waltham and New York, including a 110,000-square-foot laboratory and office complex intended to markedly increase preclinical capacity and support foreign biotechs entering the U.S. market. The expansion is presented as part of a broader growth strategy tied to scaling facilities and capabilities.